Exit
Register
Login
2025 SPS Seattle | Taletrectinib Pushing Boundaries in ROS1 Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Taletrectinib Pushing Boundaries in ROS1 Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Finish Course
You need to enroll in this course to view this chapter
Taletrectinib Pushing Boundaries in ROS1 Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Enroll
0% Course Complete